AI assistant
Emergent BioSolutions Inc. — Director's Dealing 2018
Oct 17, 2018
32870_dirs_2018-10-17_382ac6de-2379-4aed-bccf-a00a7d782690.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Emergent BioSolutions Inc. (EBS)
CIK: 0001367644
Period of Report: 2018-10-15
Reporting Person: Havey Adam (EVP, Business Operations)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2018-10-15 | Common Stock | M | 6165 | $25.62 | Acquired | 36079 | Direct |
| 2018-10-15 | Common Stock | S | 6165 | $60.1549 | Disposed | 29914 | Direct |
| 2018-10-15 | Common Stock | M | 6165 | $25.62 | Acquired | 36079 | Direct |
| 2018-10-15 | Common Stock | S | 6165 | $60.0293 | Disposed | 29914 | Direct |
| 2018-10-15 | Common Stock | S | 661 | $60.67 | Disposed | 29253 | Direct |
| 2018-10-16 | Common Stock | M | 6165 | $25.62 | Acquired | 35418 | Direct |
| 2018-10-16 | Common Stock | S | 6165 | $61.50 | Disposed | 29253 | Direct |
| 2018-10-16 | Common Stock | M | 3840 | $25.62 | Acquired | 33093 | Direct |
| 2018-10-16 | Common Stock | S | 3840 | $63.50 | Disposed | 29253 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2018-10-15 | Stock Option (Right to Buy) | $25.62 | M | 6165 | Disposed | 2021-03-10 | Common Stock (6165) | Direct |
| 2018-10-15 | Stock Option (Right to Buy) | $25.62 | M | 6165 | Disposed | 2021-03-10 | Common Stock (6165) | Direct |
| 2018-10-16 | Stock Option (Right to Buy) | $25.62 | M | 6165 | Disposed | 2021-03-10 | Common Stock (6165) | Direct |
| 2018-10-16 | Stock Option (Right to Buy) | $25.62 | M | 3840 | Disposed | 2021-03-10 | Common Stock (3840) | Direct |
Footnotes
F1: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Havey.
F2: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.31 to $60.67, inclusive.
F3: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.50 to $60.67, inclusive.
F4: Consists of an option granted under the company's stock incentive plan as amended and restated.
F5: The option grant vested in three equal installments on the day prior to the first, second and third anniversary dates of the grant.